围肝门外科技术体系治疗肝门胆管癌

doi:10.16139/j.1007-9610.2019.02.002

外科理论与实践 ›› 2019, Vol. 24 ›› Issue (02): 96-99.doi: 10.16139/j.1007-9610.2019.02.002

围肝门外科技术体系治疗肝门胆管癌

王坚

上海交通大学医学院附属仁济医院胆胰外科,上海 200127

收稿日期:2019-01-24 出版日期:2019-03-25 发布日期:2019-04-25
通讯作者: 王坚,E-mail: dr_wangjian@126.com
基金资助:
上海市教育委员会高水平地方高校建设协同创新团队激励计划; 上海市领军人才; 上海市科学技术委员会项目（16411952700）; 促进市级医院临床技能与临床创新能力三年行动计划（16CR2002A）

Peri⁃hilar surgical system in treatment of hilar cholangiocarcinoma

WANG Jian

Received:2019-01-24 Online:2019-03-25 Published:2019-04-25

摘要/Abstract

关键词: 围肝门外科技术, 肝门胆管癌, 顺逆结合肝门显露路径, 精准外科

中图分类号:

R735.8

王坚. 围肝门外科技术体系治疗肝门胆管癌[J]. 外科理论与实践, 2019, 24(02): 96-99.

[1] Lee HY, Kim SH, Lee JM, et al.Reoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria[J]. Radiology,2006,239(1):113-121.
[2] Chryssou E, Guthrie JA, Ward J, et al.Hilar cholangiocarcinoma: MR correlation with surgical and histological findings[J]. Clin Radiol,2010,65(10):781-788.
[3] Ni Q, Wang H, Zhang Y, et al.MDCT assessment of resectability in hilar cholangiocarcinoma[J]. Abdom Radiol(NY),2017,42(3):851-860.
[4] Park HS, Lee JM, Choi JY, et al.Preoperative evaluation of bile duct cancer: MRI combined with MR cholangiopancreatography versus MDCT with direct cholangiography[J]. Am J Roentgenol,2008,190(2):396-405.
[5] Sakamoto E, Nimura Y, Hayakawa N, et al.The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases[J]. Ann Surg,1998,227(3):405-411.
[6] 董家鸿, 项灿宏. 肝门部胆管癌的精准外科手术治疗[J]. 中华消化外科杂志,2013,12(3):170-173.
[7] Kawabata Y, Hayashi H, Yano S, et al.Liver parenchyma transection-first approach in hemihepatectomy with en bloc caudate lobectomy for hilar cholangiocarcinoma: A safe technique to secure favorable surgical outcomes[J]. J Surg Oncol,2017,115(8):963-970.
[8] Kuriyama N, Isaji S, Tanemura A, et al.Transhepatic hilar approach for perihilar cholangiocarcinoma: significance of early judgment of resectability and safe vascular reconstruction[J]. J Gastrointest Surg,2017,21(3):590-599.
[9] Nagino M, Ebata T, Yokoyama Y, et al.Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections[J]. Ann Surg,2013,258(1):129-140.
[10] Capussotti L, Muratore A, Polastri R, et al.Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival[J]. J Am Coll Surg,2002,195(5):641-647.
[11] Hirano S, Kondo S, Tanaka E, et al.Outcome of surgical treatment of hilar cholangiocarcinoma: a special reference to postoperative morbidity and mortality[J]. J Hepatobiliary Pancreat Surg,2010,17(4):455-462.
[12] Chen XP, Lau WY, Huang ZY, et al.Extent of liver resection for hilar cholangiocarcinoma[J]. Br J Surg,2009, 96(10):1167-1175.
[13] Neuhaus P, Jonas S, Bechstein WO, et al.Extended resections for hilar cholangiocarcinoma[J]. Ann Surg,1999, 230(6):808-818.
[14] 王坚. 围肝门外科技术处理围肝门胆道肿瘤[J]. 中华外科杂志,2018,56(5):332-337.
[15] 王坚, 陈炜. 围肝门外科技术在胆道外科的应用[J]. 中华消化外科杂志,2015,14(4):284-287.
[16] 王坚. 围肝门外科技术在肝门部胆肠吻合的应用[J]. 肝胆外科杂志,2018,26(3):164-166.
[17] Ni Q, Wang H, Liang X, et al.Successful parenchyma-sparing anatomical sugery by 3-dimensional reconstruction of hilar cholangiocarcinoma combined with anatomic variation[J]. J Coll Physicians Surg Pak,2016,26(6 suppl):S13-S15.
[18] 何敏, 王昊陆, 闫加艳, 等. 顺逆结合肝中裂劈开肝门显露法治疗Bismuth Ⅲ、Ⅳ型肝门胆管癌的安全性与疗效分析[J]. 中华外科杂志,2018,56(5):360-366.
[19] Loschner C, Nagel SN, Kausche S, et al.Hepatic arterial supply in 1297 CT-angiographies[J]. Rofo,2015,187(4):276-282.
[20] 董家鸿, 郑树森, 陈孝平, 等. 肝切除术前肝脏储备功能评估的专家共识(2011版)[J]. 中华消化外科杂志,2011,10(1):20-25.
[21] Bai T, Chen J, Xie ZB, et al.Combined portal vein resection for hilar cholangiocarcinoma[J]. Int J Clin Exp Med,2015,8(11):21044-21052.
[22] Chen W, Ke K, Chen YL.Combined portal vein resection in the treatment of hilar cholangiocarcinoma: A systema-tic review and meta-analysis[J]. EJSO,2014,40(5):489-495.
[23] 中华医学会外科学分会. 胆道手术缝合技术与缝合材料选择中国专家共识(2018版)[J].中国实用外科杂志,2019,39(1):15-20.
[24] Mansour JC, Aloia TA, Crane CH, et al.Hilar cholangiocarcinoma: expert consensus statement[J]. HPB(Oxford),2015,17(8):691-699.

围肝门外科技术体系治疗肝门胆管癌

Peri⁃hilar surgical system in treatment of hilar cholangiocarcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 11

编辑推荐

Metrics

本文评价

[1]	杨传鑫, 王坚. 运用精准外科理念提高腹膜后肿瘤外科治疗的规范性与安全性[J]. 外科理论与实践, 2022, 27(06): 517-520.
[2]	王开宇, 王良, 束斌, 张跃伟, 黄鑫, 葛夏青, 肖鸣, 张琪佳, 严哲, 宋研, 项灿宏. 肝门胆管癌根治切除联合左半肝及右前叶腹侧段切除（附1例报告）[J]. 外科理论与实践, 2021, 26(05): 441-444.
[3]	李相成, 江王杰. 解剖性肝切除的沿革[J]. 外科理论与实践, 2020, 25(01): 20-24.
[4]	李敏, 陶颖, 宋陆军, 倪晓凌, 锁涛, 刘寒, 石洪成, 刘厚宝. CT血管成像评估肝门胆管癌的可切除性[J]. 外科理论与实践, 2019, 24(02): 131-134.
[5]	王吉文, 沈盛, 倪小健, 王越琦, 刘寒, 刘厚宝. 三维可视化技术在肝门胆管癌术前评估中的应用[J]. 外科理论与实践, 2019, 24(02): 126-130.
[6]	仇毓东, 毛谅,. 肝门胆管癌手术质量控制体系初探[J]. 外科理论与实践, 2016, 21(03): 196-199.
[7]	李相成, 焦臣宇, 王科, 成峰, 姚爱华, 吴晓峰, 沈建, 韩晟, 王东, 季顾惟, 王荇, 王学浩,. 肝门胆管癌根治性切除的结果和预后[J]. 外科理论与实践, 2016, 21(03): 206-211.
[8]	陈炜,吴志勇. 缺血预处理对肝脏缺血再灌注损伤保护作用的研究[J]. 外科理论与实践, 2003, 8(06): 513-515.
[9]	彭承宏. 肝门胆管癌手术难点及对策[J]. 外科理论与实践, 2003, 8(02): 97-98.
[10]	彭淑牖,牟一平,蔡秀军,彭承宏,吴育连,曹利平,江献川,许元良,刘颖斌. Bismuth　Ⅲ型肝门胆管癌的外科治疗[J]. 外科理论与实践, 2000, 5(04): 228-230.
[11]	李嘉根,李智涛,仇保渭. 肝门胆管癌外科治疗的体会[J]. 外科理论与实践, 1999, 4(03): 237-5.